CCRM is a Canadian, not-for-profit organization supporting the development of foundational technologies that accelerate the commercialization of stem cell- and biomaterials-based products and therapies. CCRM is supported by the Centres of Excellence for Commercialization and Research (CECR) program.
CCRM Sits down with... Molly Shoichet, University of Toronto
CDI and Northwestern U. take first steps toward rebuilding an organ using manufactured human cells.
Tumor suppressor also inhibits key property of stem cells, Stanford researchers say.
ViaCyte wins US patent to manufacture human pancreatic progenitor cells.